Contraindications to the Diphtheria, Pertussis, and Tetanus (DPT) Vaccine
The absolute contraindications to DPT vaccine are severe allergic reaction (anaphylaxis) to a previous dose or vaccine component, encephalopathy within 7 days of a previous pertussis-containing vaccine, and progressive neurologic disorders. 1
Absolute Contraindications
Severe allergic reaction (anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, or pertussis-containing vaccine, or to any component of the vaccine 1
- Patients with history of anaphylaxis should be referred to an allergist to determine if they have a specific allergy to tetanus toxoid and can be desensitized to tetanus toxoid 2
Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause 1
- In such cases, DT vaccine should be administered for the remaining doses in the vaccination schedule to ensure protection against diphtheria and tetanus 2
Progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy 1
- Pertussis vaccine should not be administered to individuals with these conditions until a treatment regimen has been established and the condition has stabilized 1
Precautions (Not Absolute Contraindications)
These conditions require careful risk-benefit assessment before administering DPT:
Guillain-Barré syndrome within 6 weeks after a previous dose of tetanus toxoid-containing vaccine 2
- If decision is made to continue tetanus toxoid immunization, Tdap is preferred if otherwise indicated 2
Temperature of ≥40.5°C (105°F) within 48 hours after a previous dose of DTP/DTaP not due to another identifiable cause 2
Collapse or shock-like state (hypotonic-hyporesponsive episode) within 48 hours after receiving a previous dose of DTP/DTaP 2
Persistent, inconsolable crying lasting ≥3 hours within 48 hours after receiving a previous dose of DTP/DTaP 2
Seizures with or without fever occurring within 3 days after receiving a previous dose of DTP/DTaP 2
History of Arthus-type hypersensitivity reactions after a previous dose of tetanus or diphtheria toxoid-containing vaccines; defer vaccination until at least 10 years have elapsed since the last tetanus toxoid-containing vaccine 2
Moderate or severe acute illness with or without fever 2
Special Considerations
For children at higher risk for seizures than the general population:
- An appropriate antipyretic (acetaminophen 15 mg/kg) may be administered at the time of vaccination and every 4 hours for 24 hours to reduce the possibility of post-vaccination fever 3, 1
Conditions That Are NOT Contraindications
The following are commonly misperceived as contraindications but are NOT reasons to avoid DPT vaccination:
- Mild acute illness with or without fever 2
- Mild-to-moderate local reaction or low-grade fever after previous dose 2
- Current antimicrobial therapy 2
- Convalescent phase of illness 2
- Preterm birth 2
- Recent exposure to an infectious disease 2
- History of allergies other than anaphylaxis to vaccine components (including penicillin allergy) 2
- Family history of seizures, sudden infant death syndrome, or adverse events after DTP/DTaP 2
- Stable neurologic conditions (e.g., cerebral palsy, well-controlled seizures, developmental delay) 2
Clinical Decision Algorithm
Assess for absolute contraindications:
- If present → Do not administer pertussis-containing vaccine; use DT instead for children or Td for older individuals
- If absent → Proceed to next step
Assess for precautions:
- If present → Evaluate risk-benefit ratio
- If benefits outweigh risks → Administer vaccine
- If risks outweigh benefits → Use alternative vaccine (DT/Td)
For patients with history of seizures or at high risk:
- Consider prophylactic acetaminophen (15 mg/kg) at time of vaccination and every 4 hours for 24 hours 3
Remember that proper assessment of contraindications is essential to balance the benefits of protection against these serious diseases with the risks of adverse reactions in individual patients.